Cugnaux, France

Fabrice Pierre

This inventor holds 1 USPTO granted patent. Top assignees: Bayerische Julius-Maximilians-Universitat Wurzburg, National Institute for Agricultural Research. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fabrice Pierre. Retrieved from https://idiyas.com/inventor/fabrice-pierre-5rfhec02

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fabrice Pierre: Innovator in Cytopathic Agents

Introduction

Fabrice Pierre is a notable inventor based in Cugnaux, France. He has made significant contributions to the field of biotechnology, particularly in the use of specific DNA molecules as cytopathic agents. His innovative work has the potential to impact various medical applications.

Latest Patents

Fabrice Pierre holds a patent for the "Use of cells containing a specific DNA molecule as cytopathic agents to inhibit the proliferation of cells." This invention relates to the use of cells that contain a specific DNA molecule in their genome, which can inhibit the proliferation of other cells when they come into contact. This groundbreaking approach could lead to advancements in therapeutic strategies.

Career Highlights

Throughout his career, Fabrice Pierre has worked with prestigious institutions, including the Institut National de la Recherche Agronomique and the University of Würzburg. His experience in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Fabrice has collaborated with notable colleagues such as Eric Oswald and Jörg Hacker. These partnerships have contributed to the advancement of his research and the successful development of his patent.

Conclusion

Fabrice Pierre is a distinguished inventor whose work in cytopathic agents showcases his innovative spirit and dedication to advancing biotechnology. His contributions have the potential to influence future medical treatments and research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…